Ono Pharmaceutical Co., Ltd.
Notice Regarding Disposal of Treasury Stock by Third-Party Allotment
On March 25, 2026, 8,398,300 common shares were disposed of at 2,435.5 yen per share, totaling 20,454,059,650 yen, to The Master Trust Bank of Japan, introducing an ESOP trust for stock grants.
Key Figures
- Number of Shares Disposed: 8,398,300 shares
- Disposal Price: 2,435.5 yen per share
- Total Disposal Amount: 20,454,059,650 yen
AI要約
Overview of Capital Policy
Ono Pharmaceutical Co., Ltd. resolved at its board meeting on March 5, 2026, to dispose of treasury stock by third-party allotment. The number of shares disposed is 8,398,300 common shares at a disposal price of 2,435.5 yen per share, totaling 20,454,059,650 yen, to The Master Trust Bank of Japan, Ltd. (stock grant ESOP trust account). This disposal is associated with the introduction of a long-term incentive stock compensation scheme for employees of its U.S. subsidiary, Deciphera Pharmaceuticals, Inc., through an ESOP trust. The trust agreement is scheduled to be executed on March 23, 2026.
Impact and Procedures for Shareholders
The number of shares disposed represents a 1.68% dilution against the total issued shares of 498,692,800, with minimal anticipated impact on the stock market. The disposal price was calculated based on the closing price as of March 4, 2026, and all statutory auditors recognized the price as reasonable. Furthermore, since the dilution rate is below 25% and there is no change in controlling shareholders, neither an independent third-party opinion from the Tokyo Stock Exchange nor shareholder consent procedures are required. The trust period is planned from March 23, 2026, to March 31, 2029, with voting rights exercised according to instructions from the trust administrator.
